Infectious disease test kit AccuPower®
virusinfluenza Anasopharyngeal

infectious disease test kit
infectious disease test kit
Add to favorites
Compare this product
 

Characteristics

Applications
for infectious diseases
Micro-organism
virus, influenza A
Sample type
nasopharyngeal
Analysis mode
real-time

Description

AccuPower® new InfA (H1N1) & InfA Real-Time RT-PCR Kit is an in vitro diagnostic kit designed for the detection of influenza A (H1N1-2009, common) virus RNA in human samples such as nasopharyngeal swab and bronchoalveolar lavage (BAL) through real-time PCR. Product Description Influenza occurs all over the world, with an annual global attack rate estimated at 5–10% in adults and 20–30% in children. In temperate regions, influenza is a seasonal disease occurring typically in winter months. The subtypes of influenza A viruses are determined by envelope glycoproteins possessing either haemagglutinin (HA) or neuraminidase (NA) activity. Influenza A (H1N1) virus emerged in 2009 is a new reassortment that has never before circulated among humans. This virus is not closely related to previous or current human seasonal influenza viruses. Features and Benefits Signature Convenience: One-step RT-PCR premix type. All components for the assay are contained within a tube. Enhanced Sensitivity & Specificity: Bioneer’s proprietary HotStart technology accomplishes high sensitivity and specificity. Remarkable Stability: Vacuum-dried premix allows stable and reproducible results. High Quality: All diagnostic kits manufactured by Bioneer are under strict quality control guidelines. Low coefficient of variation: Low coefficient of variation (CV) for between-day precision and inter-instrument trueness within 2.02 %

Other Bioneer Corporation products

PCR & RT-PCR

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.